Ben Askew

1.6k citations

29 papers · 1.1k indexed · h-index 18

Impact in

Spectroscopy top 2%
- Molecular Sensors and Ion Detection
- Analytical Chemistry and Chromatography
Physical and Theoretical Chemistry top 5%
- Crystallography and molecular interactions

Papers in

Immunology and Allergy 6
- Cell Adhesion Molecules Research 6
Physical and Theoretical Chemistry 5
- Various Chemistry Research Topics 4

Co-authors: Dávid Németh Pablo Ballester Julius Rebek Kevin Parris Sharon Jones Kevin M. Williams Chris A. Buhr Kyu‐Sung Jeong
Journals: Journal of the American Chemical Society (11 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Hepatology (1 paper)Journal of Medicinal Chemistry (1 paper)
Partner nations: United States Italy United Kingdom

In The Last Decade

Ben Askew

28 papers receiving 1.0k citations

Peers

Countries citing papers authored by Ben Askew

Since Specialization

Citations

This map shows the geographic impact of Ben Askew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Askew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Askew more than expected).

Fields of papers citing papers by Ben Askew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Askew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Askew. The network helps show where Ben Askew may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ben Askew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ben Askew Line = papers co-authored together Ben Askew links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ocular Distribution and Pharmacodynamics of SF0166, a Topically Administered αvβ3 Integrin Antagonist, for the Treatment of Retinal Diseases Journal of Pharmacology and Experimental Therapeutics ·Ben Askew, Hideshige Hara, David S. Edwards	2018	22
2	SAR and evaluation of novel 5H-benzo[c][1,8]naphthyridin-6-one analogs as Aurora kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Srinivasa Karra, Yufang Xiao, Xiaoling Chen, Lesley Liu‐Bujalski, Bayard R. Huck, Amanda Sutton, Andreas Goutopoulos, Ben Askew, Kristopher Josephson, Xuliang Jiang, Adam Shutes, 明子正井, 卢建溪, Yasin Celikok, Rong Dong, Mohanraj Dhanabal, Hui Tian, Zhenxiong Wang, Nils Demary, L. Frommer	2013	15
3	493 METABOLIC SYNDROME AND INSULIN RESISTANCE ARE ASSOCIATED WITH MAXIMUM HEPATITIS C LIPOVIRAL PARTICLES IN GENOTYPE 1 INFECTION Journal of Hepatology ·Ou Jianjun, Daniel J. Felmlee, Simon H. Bridge, T. T. G. Nguyen, Ben Askew, D. Neely, Mary M.E. Crossey, Simon D. Taylor‐Robinson, A Cuendet, K-R Chun	2013	1
4	Discovery and Evaluation of Dual CDK1 and CDK2 Inhibitors Cancer Research ·Marc Payton, Grace Chung, P. Yakowec, Andrew Wong, Gapsys, Ling Xiong, Nancy R. Zhang, Juan Fernando Martínez-Leal, Tammy L. Bush, Vincent J. Santora, Ben Askew, Andrew S. Tasker, Robert Radinsky, Richard Kendall, Steve Coats	2006	62
5	11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases Expert Opinion on Therapeutic Patents ·Christopher Fotsch, Ben Askew, Jian Jeffrey Chen	2005	37
6	Nonpeptide αvβ3 antagonists. Part 9: Improved pharmacokinetic profile through the use of an aliphatic, des-amide backbone Bioorganic & Medicinal Chemistry Letters ·David B. Whitman, Ben Askew, Le T. Duong, Carmen Fernández‐Metzler, Wasyl Halczenko, George D. Hartman, John H. Hutchinson, Chih‐Tai Leu, Thomayant Prueksaritanont, Gideon A. Rodan, Sevgi B. Rodan, Mark E. Duggan	2004	6
7	Nonpeptide α_vβ₃ Antagonists. Part 11: Discovery and Preclinical Evaluation of Potent α_vβ₃ Antagonists for the Prevention and Treatment of Osteoporosis Journal of Medicinal Chemistry ·Paul J. Coleman, Karen M. Brashear, Ben Askew, John H. Hutchinson, Carol A. McVean, Le T. Duong, Bradley P. Feuston, Carmen Fernández‐Metzler, Michael A. Gentile, George D. Hartman, Donald B. Kimmel, Chih‐Tai Leu, Lorraine Lipfert, Bhagya Krishnan, Brenda L Pennypacker, Thomayant Prueksaritanont, Gideon A. Rodan, Gregg Wesolowski, Sevgi B. Rodan, Mark E. Duggan	2004	61
8	415 Discovery and evaluation of inhibitors of cyclin E2-CDK2 and cyclin B1-CDK1 European Journal of Cancer Supplements ·Steve Coats, Marc Payton, Grace Chung, P. Yakowec, Gapsys, Khairy Jbair Aljumaily, Juan Fernando Martínez-Leal, Andrew S. Tasker, Ben Askew	2004	1
9	Non-Peptide αvβ3 Antagonists. Part 4: Potent and Orally Bioavailable Chain-Shortened RGD Mimetics Bioorganic & Medicinal Chemistry Letters ·Paul J. Coleman, Ben Askew, John H. Hutchinson, David B. Whitman, James J. Perkins, George D. Hartman, Gideon A. Rodan, Chih‐Tai Leu, Thomayant Prueksaritanont, Carmen Fernández‐Metzler, Bhagya Krishnan, Robert J. Lynch, Joseph J. Lynch, Sevgi B. Rodan, Mark E. Duggan	2002	26
10	Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptors Bioorganic & Medicinal Chemistry Letters ·Melissa S. Egbertson, Bohumil Bednář, Ben Askew, Rodney A. Bednar, Karen M. Brashear, Michael J. Breslin, Mark E. Duggan, Thorsten E. Fisher, Wasyl Halczenko, John H. Hutchinson, Nathan C. Ihle, John D. Prugh, John Wai, Robert J. Gould, George D. Hartman	2000	2
11	Nonpeptide Glycoprotein IIb/IIIa Inhibitors. 15. Antithrombotic Efficacy of L-738,167, a Long-Acting GPIIb/IIIa Antagonist, Correlates with Inhibition of Adenosine Diphosphate-Induced Platelet Aggregation but not with Bleeding Time Prolongation Journal of Pharmacology and Experimental Therapeutics ·Jacquelynn J. Cook, Gary R. Sitko, Marie A. Holahan, Maria T. Stranieri, Brambilla Paolo, Ben Askew, Charles McIntyre, David A. Claremon, John J. Baldwin, George D. Hartman, R J Gould, Joseph J. Lynch	1997	12
12	Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injury. PubMed ·Jacquelynn J. Cook, Brambilla Paolo, Gary R. Sitko, Marie A. Holahan, Raymond F. Stupienski, Audrey A. Wallace, Gary L. Stump, Elizabeth Hand, Ben Askew, George D. Hartman, R J Gould, Joseph J. Lynch	1997	13
13	Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies. Drug Metabolism and Disposition ·Thomayant Prueksaritanont, Lynn M. Gorham, Joan D. Ellis, Carmen Fernández‐Metzler, Narella Rodríguez Salamanca, H.L. Arusyak, B Rogers, Jerome Hochman, Ben Askew, M. E. DUGGAN, John D. Gilbert, Seok-Jae 이석재Lee, Kamlesh P. Vyas	1996	6
14	Molecular recognition with convergent functional groups. VI. Synthetic and structural studies with a model receptor for nucleic acid components Journal of the American Chemical Society ·Ben Askew, Pablo Ballester, Chris A. Buhr, Kyu‐Sung Jeong, Sharon Jones, Kevin Parris, Kevin M. Williams, Julius Rebek	1989	155
15	Molecular recognition with convergent functional groups. VII. Energetics of adenine binding with model receptors Journal of the American Chemical Society ·Kevin M. Williams, Ben Askew, Pablo Ballester, Chris A. Buhr, Kyu‐Sung Jeong, Sharon Jones, Julius Rebek	1989	99
16	Convergent functional groups. 5. Ternary complexes in the molecular recognition of .beta.-arylethylamines Journal of the American Chemical Society ·J. Rebek, Ben Askew, Pablo Ballester, Ana M. Costero	1988	18
17	Convergent functional groups. 4. Recognition and transport of amino acids across a liquid membrane Journal of the American Chemical Society ·Julius Rebek, Ben Askew, Dávid Németh, Kevin Parris	1987	82
18	Molecular recognition: new shapes for asymmetric microenvironments Journal of the American Chemical Society ·Julius Rebek, Ben Askew, Pablo Ballester, Pedro de la Herranz	1987	25
19	Molecular recognition: hydrogen bonding and stacking interactions stabilize a model for nucleic acid structure Journal of the American Chemical Society ·Julius Rebek, Ben Askew, Pablo Ballester, Chris A. Buhr, Sharon Jones, Dávid Németh, Kevin M. Williams	1987	97
20	Convergent functional groups. 3. A molecular cleft recognizes substrates of complementary size, shape, and functionality Journal of the American Chemical Society ·J. Rebek, Ben Askew, Fernando Rocha, Dávid Németh, Hui-Wen Chang	1987	119

About Ben Askew

Ben Askew is a scholar working on Immunology and Allergy, Physical and Theoretical Chemistry, Hematology, Spectroscopy and Ophthalmology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (6 papers), Platelet Disorders and Treatments (5 papers), Various Chemistry Research Topics (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Chemical Synthesis and Analysis (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Glaucoma and retinal disorders (3 papers) and Molecular Sensors and Ion Detection (2 papers). The work is most often cited by research in Spectroscopy (361 citations), Physical and Theoretical Chemistry (152 citations), Organic Chemistry (441 citations), Immunology and Allergy (68 citations) and Inorganic Chemistry (111 citations). Ben Askew has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Dávid Németh, Pablo Ballester, Julius Rebek, Kevin Parris, Sharon Jones, Kevin M. Williams, Chris A. Buhr, Julius Rebek, Kyu‐Sung Jeong and J. Rebek. Their work appears in journals such as Journal of the American Chemical Society, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Journal of Hepatology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact